Schedule 13G ownership disclosure
Taysha Gene Therapies Inc
Common Stock, $0.00001 par value per share · CUSIP: 877619106
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 27,662,481.00 · Class: 9.9%
- Peter Kolchinsky
Shares: 27,662,481.00 · Class: 9.9%
- Rajeev Shah
Shares: 27,662,481.00 · Class: 9.9%
- RA Capital Healthcare Fund, L.P.
Shares: 27,662,481.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001231919-25-000491
- Form type
- SCHEDULE 13G/A
- Filer
- RA CAPITAL MANAGEMENT, L.P.
- CIK
- CIK 1346824
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership